The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Evolve From 2026 To 2030?
The investigational new drug contract development and manufacturing organization (cdmo) market size has demonstrated substantial growth in recent years. It is anticipated to expand from $5.91 billion in 2025 to $6.33 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.1%. This historical growth can be linked to factors such as the limited availability of CDMOs for investigational drugs, an increasing demand for small molecule synthesis, reliance on conventional manufacturing services, growing clinical trial volumes, and the early adoption of regulatory support services.
The investigational new drug contract development and manufacturing organization (cdmo) market is projected to experience robust expansion in the coming years, anticipated to reach $8.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This forecasted growth can be linked to several factors, including the increasing capacity for gene and cell therapy manufacturing, a surge in demand for monoclonal antibodies and recombinant proteins, significant investment in advanced formulation technologies, the implementation of scalable manufacturing platforms, and an increase in global biotechnology research partnerships. Key trends projected for this period encompass a heightened need for early-stage drug development support, an expansion in services related to clinical trial material supply, an intensified emphasis on adherence to regulatory and quality benchmarks, the broadening of biologics and advanced therapy development, and the uptake of bespoke manufacturing solutions for both small and large molecular compounds.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25803&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
The investigational new drug contract development and manufacturing organization (CDMO) market is projected to grow, driven by the increasing number of clinical trials. These trials are structured studies involving human participants, designed to assess the safety and efficacy of medical treatments, procedures, or interventions under controlled conditions. This rise in clinical trials is largely fueled by the escalating demand for innovative treatments, as the growing incidence of chronic and complex diseases pushes pharmaceutical and biotech companies to develop and test new therapies. Investigational new drug CDMOs contribute to clinical trials by streamlining the development and manufacturing of trial-ready drug formulations, ensuring a prompt and compliant supply of investigational products for each study phase. For instance, in December 2024, the Association of the British Pharmaceutical Industry, a UK-based pharmaceutical industry trade association, reported that the total number of industry-sponsored clinical trials initiated in the United Kingdom rose from 411 in 2022 to 426 in 2023. Additionally, Phase III trial initiations expanded by 16.5 percent during the same period, increasing from 182 to 212. Consequently, the rising volume of clinical trials is propelling the expansion of the investigational new drug contract development and manufacturing organization (CDMO) market.
Which Segment Areas Are Covered In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Analysis?
The investigational new drug contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Small Molecules, Large Molecules
2) By Formulation Type: Solid Formulations, Liquid Formulations, Injectable Formulations
3) By Service Type: Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services
4) By End-User: Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Small Molecules: Synthetic Small Molecules, Semi-synthetic Small Molecules, Peptide-based Small Molecules, Oligonucleotides
2) By Large Molecules: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Cell Therapy Products, Gene Therapy Products, RNA-based Therapeutics
What Key Developments And Trends Are Impacting The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the investigational new drug contract development and manufacturing organization (CDMO) market are focusing on strategic partnerships to strengthen development capabilities and speed up clinical entry. Such partnerships involve formal alliances between two or more organizations that collaborate to achieve shared objectives, leveraging each other’s strengths, resources, or expertise to gain mutual benefits while remaining independent entities. For instance, in August 2023, Sartorius AG, a Germany-based life science company, partnered with Repligen Corporation, a US-based life sciences company, to launch an integrated system combining the BIOSTAT STR and XCell ATF technologies for upstream process intensification. This collaboration aims to streamline biopharmaceutical production by enhancing efficiency and scalability. The initiative marks Sartorius’ continued innovation in bioprocessing solutions, reinforcing its commitment to advancing the biomanufacturing industry.
Which Global Companies Are Actively Competing In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the investigational new drug contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., Amaran Biotech Inc.
Read the full investigational new drug contract development and manufacturing organization (cdmo) market report here:
What Are The Leading Geographic Regions In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the investigational new drug contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25803&type=smp
Browse Through More Reports Similar to the Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model